Nu-Med Plus (NUMD) Profit After Tax (2012 - 2025)
Nu-Med Plus (NUMD) posted Profit After Tax of -$12618.0 for Q4 2025, down 5.45% sequentially from -$11966.0 in Q3 2025, and down 19.55% YoY from -$15683.3 in Q4 2024.
Nu-Med Plus (NUMD) Profit After Tax (2012 - 2025) Analysis & Trends
Nu-Med Plus has reported Profit After Tax for 14 years, with the latest figure at -$12618.0 in Q4 2025.
- Quarterly Profit After Tax fell 19.55% year-over-year to -$12618.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$56182.0 (up 17.8% YoY) and the FY2025 annual result came in at -$56182.0, up 17.8% from the prior year.
- Profit After Tax retreated to -$12618.0 in Q4 2025 per NUMD's latest filing, from -$11966.0 in the prior quarter.
- Over five years, Profit After Tax peaked at $42606.0 in Q4 2022 and troughed at -$356748.0 in Q1 2021.
- A 5-year average of -$60514.0 and a median of -$23073.0 in 2023 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax jumped 137.93% in 2022, then tumbled 232.84% in 2023.
- Over 5 years, Profit After Tax stood at -$112341.0 in 2021, then surged by 137.93% to $42606.0 in 2022, then sank by 232.84% to -$56596.0 in 2023, then surged by 81.35% to -$10555.0 in 2024, then decreased by 19.55% to -$12618.0 in 2025.
- According to Business Quant data, Profit After Tax over the past three periods registered -$12618.0, -$11966.0, and -$11665.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 573.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 619.54 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | 19,670.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12,618.00 |
| Sep 30, 2025 | -11,966.00 |
| Jun 30, 2025 | -11,665.00 |
| Mar 31, 2025 | -19,933.00 |
| Dec 31, 2024 | -10,555.00 |
| Sep 30, 2024 | -18,677.00 |
| Jun 30, 2024 | -17,287.00 |
| Mar 31, 2024 | -21,826.00 |
| Dec 31, 2023 | -56,596.00 |
| Sep 30, 2023 | -16,406.00 |
| Jun 30, 2023 | -24,320.00 |
| Mar 31, 2023 | -28,204.00 |
| Dec 31, 2022 | 42,606.00 |
| Sep 30, 2022 | -58,050.00 |
| Jun 30, 2022 | -58,070.00 |
| Mar 31, 2022 | -56,653.00 |
| Dec 31, 2021 | -112,341.00 |
| Sep 30, 2021 | -118,366.00 |
| Jun 30, 2021 | -242,606.00 |
| Mar 31, 2021 | -356,748.00 |